Another DNA-methylation inhibitor, decitabine, has been shown to enhance γδ T cell-mediated cytotoxicity by inducing ligands for activating receptors (natural killer group 2D, member D [NKG2D] ligands [NKG2DLs]) on osteosarcoma cells (12). This evidence concerns the gene KLRK1 and osteosarcoma.